ASND – ascendis pharma a/s - american depositary shares (US:NASDAQ)
Stock Stats
News
Ascendis Pharma A/S (NASDAQ: ASND) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Ascendis Pharma A/S (NASDAQ: ASND) had its price target lowered by analysts at TD Cowen from $160.00 to $153.00. They now have a "buy" rating on the stock.
Ascendis Pharma A/S (NASDAQ: ASND) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $190.00 to $180.00. They now have an "outperform" rating on the stock.
Ascendis Pharma A/S (NASDAQ: ASND) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $170.00 price target on the stock.
Ascendis Pharma A/S (NASDAQ: ASND) had its price target raised by analysts at Stifel Nicolaus from $200.00 to $207.00. They now have a "buy" rating on the stock.
Form 144 Ascendis Pharma A/S Filed by: Hartvig Camilla Harder
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Form 6-K Ascendis Pharma A/S For: Nov 14
Form 6-K Ascendis Pharma A/S For: Sep 30
Form SC 13G/A Ascendis Pharma A/S Filed by: JANUS HENDERSON GROUP PLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.